Titlebook: Atlas of Graft-versus-Host Disease; Approaches to Diagno Jonathan A. Cotliar Book 2017 Springer International Publishing AG 2017 GVHD.Graft

凝固

書目名稱Atlas of Graft-versus-Host Disease影響因子(影響力)




書目名稱Atlas of Graft-versus-Host Disease影響因子(影響力)學(xué)科排名




書目名稱Atlas of Graft-versus-Host Disease網(wǎng)絡(luò)公開度




書目名稱Atlas of Graft-versus-Host Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Atlas of Graft-versus-Host Disease被引頻次




書目名稱Atlas of Graft-versus-Host Disease被引頻次學(xué)科排名




書目名稱Atlas of Graft-versus-Host Disease年度引用




書目名稱Atlas of Graft-versus-Host Disease年度引用學(xué)科排名




書目名稱Atlas of Graft-versus-Host Disease讀者反饋




書目名稱Atlas of Graft-versus-Host Disease讀者反饋學(xué)科排名

otic-capsule

MORT

Clinical Presentation of Acute Cutaneous Graft-Versus-Host Disease,mation of aGVHD via skin biopsy is frequently equivocal. Additional clinical information may be necessary to differentiate aGVHD from its clinical mimickers such as viral exanthema, morbilliform drug eruptions, engraftment syndrome (ES), pre-engraftment syndrome (PES), and in severe cases, Stevens-J

大門在匯總

Clinical Presentation of Mucosal Acute and Chronic Graft-Versus-Host Disease,al sites share similarities in symptoms, clinical signs, and histopathologic features. Early and accurate diagnosis of GVHD, in conjunction with timely intervention, is key to minimizing discomfort and unnecessary medication exposure, and to preventing irreversible organ damage and functional defici

brassy

Histopathology of Cutaneous Graft-Versus-Host Disease,his entity in a timely manner is often hindered by clinical and histopathologic mimickers, such as drug hypersensitivity reactions, viral exanthema, and toxic erythema of chemotherapy. Microscopic findings in acute and chronic cutaneous GVHD are reviewed here, as are features of other entities in th

Apoptosis

Coronary

Clinical Presentation of Nonsclerotic Epidermal Chronic Graft-Versus-Host Disease and Hair and Nails, but the development of graft-versus-host disease after transplantation may cause significant morbidity and mortality. The updated National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (cGVHD) [1] clarified and built upon t

Cacophonous

extinct

匯總

Diagnosis, Staging, and Treatment of Chronic Graft-Versus-Host Disease, cell transplantation (HSCT), and the incidence of cGVHD continues to rise [1]. Evolving transplantation practices, including the use of mobilized peripheral stem cells, transplantation of older recipients, and more frequent use of mismatched transplants, may explain the occurrence of this vexing pr